title: Unusual thyroiditis after recombinant interleukin-2 therapy.
authors.affiliation: Service de Médecine Interne 2, St-Vincent de Paul, Université René Descartes, 27 rue du Faubourg St-Jacques 75679 Paris, Cedex 14, France. sebastian.abad@cch.ap-hop-paris.fr
authors.forename: S
authors.initials: S
authors.lastname: Abad
authors.forename: P
authors.initials: P
authors.lastname: Blanche
authors.forename: L
authors.initials: L
authors.lastname: Moachon
authors.forename: A
authors.initials: A
authors.lastname: Brunet
authors.forename: L
authors.initials: L
authors.lastname: Héripret-Fredouille
authors.forename: D
authors.initials: D
authors.lastname: Sicard
authors.forename: D
authors.initials: D
authors.lastname: Salmon-Céron
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000328:Adult; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects*; D013968:Thyroiditis, Subacute / Q000139:chemically induced*
chemical_list: D000276:Adjuvants, Immunologic; D007376:Interleukin-2